CD35 anticorps (AA 1301-1400) (Cy3)
Aperçu rapide pour CD35 anticorps (AA 1301-1400) (Cy3) (ABIN1701784)
Antigène
Voir toutes CD35 (CR1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1301-1400
-
Specificité
- May recognize Complement component receptor 1-like protein in certain tissues, which is expressed in fetal liver and to a lesser extent in fetal spleen and thymus.
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human CR1/CD35
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- CD35 (CR1) (Complement Component Receptor 1 (CD35) (CR1))
-
Autre désignation
- CD35
-
Sujet
-
Synonyms: KN, C3BR, C4BR, CD35, Complement receptor type 1, C3b/C4b receptor, CR1
Background: Mediates cellular binding of particles and immune complexes that have activated complement.
-
ID gène
- 1378
-
UniProt
- P17927
-
Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Endopeptidase Activity
Antigène
-